[Multiple sclerosis: new treatment options]

MMW Fortschr Med. 2014 Mar 27;156 Spec No 1(1):69-73; quiz 74.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Brain / pathology
  • Crotonates
  • Dimethyl Fumarate
  • Fumarates / therapeutic use
  • Guideline Adherence
  • Humans
  • Hydroxybutyrates
  • Immunosuppressive Agents / therapeutic use
  • Interferon-beta / adverse effects
  • Interferon-beta / therapeutic use
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology
  • Neurologic Examination
  • Nitriles
  • Oligodendroglia / pathology
  • Toluidines

Substances

  • Antibodies, Monoclonal
  • Crotonates
  • Fumarates
  • Hydroxybutyrates
  • Immunosuppressive Agents
  • Nitriles
  • Toluidines
  • teriflunomide
  • Interferon-beta
  • Dimethyl Fumarate